A Study of CBP-1018 in Patients With Advanced Solid Tumors
Clinical trial NCT04928612 · RECRUITING
Trial details
- NCT number
- NCT04928612
- Sponsor
- Coherent Biopharma (Suzhou) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-04
- Primary completion
- 2024-10-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.